project id: TCGA-THCA; case submitter id: TCGA-H2-A26U; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.2; rna integrity number: 7.7; spectrophotometer method: UV Spec; age at index: 54; days to birth: -19927; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1957; age at diagnosis: 19927; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage III; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 517.0; icd 10 code: C73; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Thyroid gland; synchronous malignancy: No; tissue or organ of origin: Thyroid gland; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 27; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: a4240ab1-970e-4a99-989e-8968903e3a25; sample submitter id: TCGA-H2-A26U-01A; portion id: 607bcaba-ed63-400d-a81d-2c33b7036ba1; portion submitter id: TCGA-H2-A26U-01A-11; slide id: f876fbdb-8ec4-45e5-90a7-27e368eba611; slide submitter id: TCGA-H2-A26U-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 85.0; section location: TOP;